Evaluation of cell-free expression system for the production of soluble and functional human GPCR N-formyl peptide receptors

Protein and Peptide Letters

Volumn 20, Issue 11, 2013, Pages 1272-1279

  Wang, Xiaoqiang ^a   Wang, Jiqian ^a   Ge, Baosheng ^a  

^a CHINA UNIVERSITY OF PETROLEUM   (China)

Author keywords

Biological function; Cell free expression system; Detergent; G protein coupled receptors; N formyl peptide receptors; Secondary structure

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; FPR3 GENE; GENE; LIGAND BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; QUARTZ CRYSTAL MICROBALANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

CELL-FREE SYSTEM; ESCHERICHIA COLI; HUMANS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84887891391     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/09298665113209990043     Document Type: Article

References (33)

1. Shoichet, B.K.; Kobilka, B.K. Structure-based drug screening for G-protein-coupled receptors. Trends Pharmacol. Sci., 2012, 33, 268-272.
2. Lappano, R.; Maggiolini, M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov., 2011, 10, 47-60.
3. Heilker, R.; Wolff, M.; Tautermann, C.S.; Bieler, M. G-proteincoupled receptor-focused drug discovery using a target class platform approach. Drug Discov. Today, 2009, 14, 231-240.
4. Rosenbaum, D.M.; Rasmussen, S.G.; Kobilka, B.K. The structure and function of G-protein-coupled receptors. Nature, 2009, 459, 356-363.
5. Katritch, V.; Cherezov, V.; Stevens, R.C. Structure-function of the G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol., 2013, 53, 531-556.
6. Shibata, Y.; Gvozdenovic-Jeremic, J.; Love, J.; Kloss, B.; White, J.F.; Grisshammer, R.; Tate, C.G. Optimising the combination of thermostabilising mutations in the neurotensin receptor for structure determination. Biochim. Biophys. Acta, 2013, 1828, 1293-1301.
7. Venkatakrishnan, A.J.; Deupi, X.; Lebon, G.; Tate, C.G.; Schertler, G.F.; Babu, M.M. Molecular signatures of G-protein-coupled receptors. Nature, 2013, 494, 185-194.
8. Migeotte, I.; Communi, D.; Parmentier, M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev., 2006, 17, 501-519.
9. Panaro, M.A.; Acquafredda, A.; Sisto, M.; Lisi, S.; Maffione, A.B.; Mitolo, V. Biological role of the N-formyl peptide receptors. Immunopharmacol. Immunotoxicol., 2006, 28, 103-127.
10. Le, Y.; Yang, Y.; Cui, Y.; Yazawa, H.; Gong, W.; Qiu, C.; Wang, J.M. Receptors for chemotactic formyl peptides as pharmacological targets. Int. Immunopharmacol., 2002, 2, 1-13.
11. Le, Y.; Murphy, P.M.; Wang, J.M. Formyl-peptide receptors revisited. Trends Immunol., 2002, 23, 541-548.
12. Ye, R. D.; Boulay, F.; Wang, J.M.; Dahlgren, C.; Gerard, C.; Parmentier, M.; Serhan, C.N.; Murphy, P.M. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev., 2009, 61, 119-161.
13. Rabiet, M.J.; Macari, L.; Dahlgren, C.; Boulay, F. N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation. J. Biol. Chem., 2011, 286, 26718-26731.
14. Harada, M.; Habata, Y.; Hosoya, M.; Nishi, K.; Fujii, R.; Kobayashi, M.; Hinuma, S. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun., 2004, 324, 255-261.
15. Sterne-Marr, R.; Baillargeon, A.I.; Michalski, K.R.; Tesmer, J.J. Expression, purification, and analysis of g-protein-coupled receptor kinases. Methods Enzymol., 2013, 521, 347-366.
16. Krettler, C.; Reinhart, C.; Bevans, C.G. Expression of GPCRs in Pichia pastoris for Structural Studies. Methods Enzymol., 2013, 520, 1-29.
17. Ren, H.; Yu, D.; Ge, B.; Cook, B. L.; Xu, Z.; Zhang, S. High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1. PLoS One, 2009, 4, e4509.
18. Cook, B.L.; Steuerwald, D.; Kaiser, L.; Graveland-Bikker, J.; Vanberghem, M.; Berke, A.P.; Herlihy, K.; Pick, H.; Vogel, H.; Zhang, S. Large-scale production and study of a synthetic G proteincoupled receptor: human olfactory receptor 17-4. Proc. Natl. Acad. Sci. USA, 2009, 106, 11925-11930.
19. Klammt, C.; Schwarz, D.; Eifler, N.; Engel, A.; Piehler, J.; Haase, W.; Hahn, S.; Dötsch, V.; Bernhard, F. Cell-free production of G protein-coupled receptors for functional and structural studies. J. Struct. Biol., 2007, 158, 482-493.
20. Wang, X.; Corin, K.; Baaske, P.; Wienken, C.J.; Jerabek-Willemsen, M.; Duhr, S.; Braun, D.; Zhang, S. Peptide surfactants for cell-free production of functional G protein-coupled receptors. Proc. Natl. Acad. Sci. USA, 2011, 108, 9049-9054.
21. Reeves, P.J.; Kim, J.M.; Khorana, H.G. Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants. Proc. Natl. Acad. Sci. USA, 2002, 99, 13413-13418.
22. Park, K.H.; Billon-Denis, E.; Dahmane, T.; Lebaupain, F.; Pucci, B.; Breyton, C.; Zito, F. In the cauldron of cell-free synthesis of membrane proteins: playing with new surfactants. N. Biotechnol., 2011, 28, 255-261.
23. Kaiser, L.; Graveland-Bikker, J.; Steuerwald, D.; Vanberghem, M.; Herlihy, K.; Zhang, S. Efficient cell-free production of olfactory receptors: detergent optimization, structure, and ligand binding analyses. Proc. Natl. Acad. Sci. USA, 2008, 105, 15726-15731.
24. Wang, X.; Corin, K.; Rich, C.; Zhang, S. Study of two G-protein coupled receptor variants of human trace amine-associated receptor 5. Sci. Rep., 2011, 1, 102.
25. Wang, X.; Zhang, S. Production of a bioengineered G-protein coupled receptor of human formyl peptide receptor 3. PLoS ONE, 2011, 6, e23076.
26. Latek, D.; Modzelewska, A.; Trzaskowski, B.; Palczewski, K.; Filipek, S. G protein-coupled receptors-recent advances. Acta Biochim. Pol., 2012, 59, 515-529.
27. Ma, Y.; Kubicek, J.; Labahn, J. Expression and purification of functional human mu opioid receptor from E. coli. PLoS ONE, 2013, 8, e56500.
28. Klammt, C.; Schwarz, D.; Fendler, K.; Haase, W.; Dötsch, V.; Bernhard, F. Evaluation of detergents for the soluble expression of alpha-helical and beta-barrel-type integral membrane proteins by a preparative scale individual cell-free expression system. FEBS J., 2005, 272, 6024-6038.
29. McIntosh, C.M.; Esposito, E.A. (III); Boal, A.K.; Simard, J.M.; Martin, C.T.; Rotello, V.M. Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters. J. Am. Chem. Soc., 2001, 123, 7626-7629.
30. Goodman, C.M.; McCusker, C.D.; Yilmaz, T.; Rotello, V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem., 2004, 15, 897-900.
31. Tateyama, M.; Abe, H.; Nakata, H.; Saito, O.; Kubo, Y. Ligandinduced rearrangement of the dimeric metabotropic glutamate receptor 1alpha. Nat. Struct. Mol. Biol., 2004, 11, 637-642.
32. Kniazeff, J.; Bessis, A.S.; Maurel, D.; Ansanay, H.; Prézeau, L.; Pin, J.P. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol., 2004, 11, 706-713.
33. Grisshammer, R.; White, J.F.; Trinh, L.B.; Shiloach, J. Large-scale expression and purification of a G-protein-coupled receptor for structure determination-an overview. J. Struct. Funct. Genomics, 2005, 6, 159-163.